BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/21/2017 7:51:53 AM | Browse: 436 | Download: 203
Publication Name World Journal of Gastroenterology
Manuscript ID 34916
Country of Manuscript Source Australia
Received
2017-06-04 13:43
Peer-Review Started
2017-06-06 07:40
To Make the First Decision
2017-06-22 06:00
Return for Revision
2017-06-27 10:37
Revised
2017-07-03 11:58
Second Decision
2017-08-07 05:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-08-15 15:14
Articles in Press
2017-08-15 15:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-09-20 01:03
Publish the Manuscript Online
2017-09-21 07:51
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Review
Article Title Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
Manuscript Source Invited Manuscript
All Author List Abhinav Vasudevan, Peter R Gibson and Daniel R van Langenberg
ORCID
Author(s) ORCID Number
Abhinav Vasudevan http://orcid.org/0000-0001-5026-9014
Peter R Gibson http://orcid.org/0000-0001-9108-1712
Daniel R van Langenberg http://orcid.org/0000-0003-3662-6307
Funding Agency and Grant Number
Corresponding author Abhinav Vasudevan, BM BCh, Doctor, Gastroenterologist, Gastroenterology and Hepatology, Eastern Health and Monash University, Level 2, 5 Arnold Street, Box Hill Hospital, Box Hill 3128, Victoria, Australia. abhinav.vasudevan@gmail.com
Keywords Crohn’s disease; clinical pharmacology; ulcerative colitis; thiopurines; Inflammatory bowel disease; biologics; nutrition
Core Tip There appears to be marked variation in time to clinical response for therapies used in inflammatory bowel disease which is further influenced by disease and patient related factors. The most rapid response can be expected with corticosteroids, calcineurin inhibitors, exclusive enteral nutrition, aminosalicylates and anti-tumor necrosis factor therapy (within 2 mo), while methotrexate, thiopurines and vedolizumab can take several months to achieve maximal response. There is a lack of reporting of the time to response of therapies in clinical trials for inflammatory bowel disease and this remains an area that should be addressed in future studies.
Publish Date 2017-09-21 07:51
Citation Vasudevan A, Gibson PR, van Langenberg DR. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told? World J Gastroenterol 2017; 23(35): 6385-6402
Url http://www.wjgnet.com/1007-9327/full/v23/i35/6385.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i35.6385
Full Article (PDF) WJG-23-6385.pdf
Full Article (Word) WJG-23-6385.doc
Manuscript File 34916-Review.docx
Answering Reviewers 34916-Answering reviewers.pdf
Audio Core Tip 34916-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 34916-Conflict-of-interest statement.pdf
Copyright License Agreement 34916-Copyright-Assignment-revision.pdf
Peer-review Report 34916-Peer-review(s).pdf
Scientific Misconduct Check 34916-Scientific misconduct check.pdf
Scientific Editor Work List 34916-Scientific editor work list.pdf